Inovio Pharmaceuticals And NASDAQ TEST STOCK On The List Of Winners And Losers Of Friday’s US Session

(VIANEWS) – Another day of trading has ended and here’s today‚Äôs list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Inovio Pharmaceuticals, Zhongchao, and Xeris Pharmaceuticals.

Rank Financial Asset Price Change Updated (EST)
1 Inovio Pharmaceuticals (INO) 0.66 15.35% 2024-01-05 12:13:05
2 Zhongchao (ZCMD) 0.38 15.15% 2024-01-05 03:12:05
3 Xeris Pharmaceuticals (XERS) 2.53 12.95% 2024-01-05 01:14:05
4 VirTra (VTSI) 11.00 11.79% 2024-01-04 21:23:06
5 Peloton (PTON) 6.81 11.1% 2024-01-05 12:17:08
6 Yield10 Bioscience (YTEN) 0.25 9.3% 2024-01-05 03:10:06
7 AMREP Corporation (AXR) 21.95 8.02% 2024-01-05 15:11:06
8 Globalstar (GSAT) 2.03 6.02% 2024-01-05 13:01:12
9 Grupo Aval Acciones y Valores S.A. ADR (AVAL) 2.57 4.9% 2024-01-05 14:23:06
10 Orix Corp (IX) 97.81 4.83% 2024-01-05 12:21:14

The three biggest losers today are NASDAQ TEST STOCK, VerifyMe, and Xenetic Biosciences.

Rank Financial Asset Price Change Updated (EST)
1 NASDAQ TEST STOCK (ZVZZT) 11.01 -62.85% 2024-01-05 04:23:05
2 VerifyMe (VRMEW) 0.03 -39.6% 2024-01-04 21:10:06
3 Xenetic Biosciences (XBIOW) 4.00 -34.43% 2024-01-05 01:10:06
4 Catalyst Pharmaceuticals (CPRX) 14.78 -13.59% 2024-01-05 12:11:24
5 WW International (WW) 6.79 -11.13% 2024-01-05 01:07:05
6 Marathon (MARA) 23.42 -10.85% 2024-01-05 12:13:30
7 111 (YI) 1.67 -8.74% 2024-01-05 02:23:06
8 Riot Blockchain (RIOT) 14.50 -8.58% 2024-01-05 12:17:15
9 WISeKey International Holding AG (WKEY) 1.78 -7.77% 2024-01-04 23:12:05
10 voxeljet AG (VJET) 1.21 -6.92% 2024-01-04 19:44:05

Winners today

1. Inovio Pharmaceuticals (INO) – 15.35%

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company engages in conducting and planning clinical studies of its DNA medicines for HPV-associated precancers. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia, including cervical, vulvar, and anal dysplasia and is under phase II/III clinical trials; INO-3107 for HPV-related recurrent respiratory rapillomatosis and is under Phase 1/2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under phase 1b trial; and INO-4500 vaccine for lassa fever, which is under phase 1b trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

NASDAQ ended the session with Inovio Pharmaceuticals jumping 15.35% to $0.66 on Friday, following the last session’s upward trend. NASDAQ jumped 0.09% to $14,524.07, after five successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, Inovio Pharmaceuticals has a trailing twelve months EPS of $-0.63.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.3%.

Volatility

Inovio Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was 1.51%, 1.74%, and 4.79%.

Inovio Pharmaceuticals’s highest amplitude of average volatility was 9.08% (last week), 4.65% (last month), and 4.79% (last quarter).

Moving Average

Inovio Pharmaceuticals’s worth is way above its 50-day moving average of $0.40 and way above its 200-day moving average of $0.55.

Volume

Today’s last reported volume for Inovio Pharmaceuticals is 6013370 which is 54.31% above its average volume of 3896870.

More news about Inovio Pharmaceuticals.

2. Zhongchao (ZCMD) – 15.15%

Zhongchao Inc. provides healthcare information, education, and training services in China. It offers online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company operates through its mdmooc.org online platform, as well as Sunshine Health Forums, a Wechat subscription account and mobile app. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China.

NASDAQ ended the session with Zhongchao jumping 15.15% to $0.38 on Friday, following the last session’s upward trend. NASDAQ jumped 0.09% to $14,524.07, after five consecutive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Zhongchao has a trailing twelve months EPS of $-0.36.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -25.47%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 42.2%, now sitting on 17.23M for the twelve trailing months.

Moving Average

Zhongchao’s value is way below its 50-day moving average of $0.81 and way under its 200-day moving average of $1.07.

More news about Zhongchao.

3. Xeris Pharmaceuticals (XERS) – 12.95%

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes ready-to-use injectable and infusible drug formulations. Its proprietary XeriSol and XeriJect formulation technology platforms allow for the subcutaneous and intramuscular delivery of highly-concentrated, ready-to-use formulations of peptides, small molecules, and proteins using commercially available syringes, auto-injectors, multi-dose pens, and infusion pumps. The company's lead product candidate is Gvoke HypoPen for the treatment of severe hypoglycemia, a potentially life-threatening condition in people with diabetes. Its product candidates also comprise ready-to-use glucagon that has completed Phase II clinical trials for the treatment of post-bariatric hypoglycemia, exercise-induced hypoglycemia in diabetes, bi-hormonal artificial pancreas closed-loop systems, congenital hyperinsulinism, and hypoglycemia-associated autonomic failure; and hypoglycemia associated with intermittent and chronic conditions. In addition, it develops ready-to-use diazepam formulation, which is in Phase Ib clinical trial for the treatment of Dravet syndrome and acute repetitive seizures in patients with epilepsy; and Pramlintide-Insulin co-formulation that is Phase II clinical trials for treating type 1 and 2 diabetes. Xeris Pharmaceuticals, Inc. serves patients, caregivers, and health practitioners. The company was founded in 2005 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with Xeris Pharmaceuticals jumping 12.95% to $2.53 on Friday, following the last session’s upward trend. NASDAQ jumped 0.09% to $14,524.07, after five successive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Xeris Pharmaceuticals has a trailing twelve months EPS of $-0.52.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -209.81%.

More news about Xeris Pharmaceuticals.

4. VirTra (VTSI) – 11.79%

VirTra, Inc. provides force training simulators, firearms training simulators, and driving simulators for law enforcement, military, educational, and civilian worldwide. The company's products comprise V-300 simulator, a 300 degree wrap-around screen for simulation training; V-180 simulator, a 180 degree screen for smaller spaces or budgets; V-100, a single-screen based simulator system; V-100 MIL, a single-screen small arms training simulator; and V-ST PRO, a realistic single screen firearms shooting and skills training simulator. It also offers V-Author, a software that allows users to create, edit, and train with content specific to agency's objectives; Simulated Recoil Kits, a range of realistic and reliable simulated recoil kits/weapons; and Threat-Fire, a return fire device that applies real-world stress on the trainees during simulation training. In addition, the company provides VirTra Driving Sim, a vehicle-based simulator; Virtual Interactive Coursework Training Academy, which enables law enforcement agencies to each, train, test, and sustain departmental training requirements; Subscription Training Equipment Partnership, a program that allows agencies to utilize VirTra's simulator products, accessories, and V-VICTA interactive coursework on a subscription basis; and TASER, an OC spray and low-light training devices. It sells its simulators and related products through a direct sales force and distribution partners. The company was formerly known as VirTra Systems, Inc. and changed its name to VirTra, Inc. in October 2016. VirTra, Inc. was founded in 1993 and is based in Tempe, Arizona.

NASDAQ ended the session with VirTra rising 11.79% to $11.00 on Friday while NASDAQ jumped 0.09% to $14,524.07.

Earnings Per Share

As for profitability, VirTra has a trailing twelve months EPS of $0.64.

PE Ratio

VirTra has a trailing twelve months price to earnings ratio of 17.19. Meaning, the purchaser of the share is investing $17.19 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.47%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 54.2%, now sitting on 36.57M for the twelve trailing months.

Yearly Top and Bottom Value

VirTra’s stock is valued at $11.00 at 16:32 EST, below its 52-week high of $11.29 and way above its 52-week low of $3.70.

Moving Average

VirTra’s value is way higher than its 50-day moving average of $7.09 and way higher than its 200-day moving average of $6.55.

More news about VirTra.

5. Peloton (PTON) – 11.1%

Peloton Interactive, Inc. operates interactive fitness platform in North America and internationally. The company offers connected fitness products with touchscreen that streams live and on-demand classes under the Peloton Bike, Peloton Bike+, Peloton Tread, Peloton Tread+, Peloton Guide, and Peloton Row names. The company markets and sells its interactive fitness products directly through its retail showrooms and at onepeloton.com. Peloton Interactive, Inc. was founded in 2012 and is headquartered in New York, New York.

NASDAQ ended the session with Peloton rising 11.1% to $6.81 on Friday while NASDAQ rose 0.09% to $14,524.07.

Earnings Per Share

As for profitability, Peloton has a trailing twelve months EPS of $-2.88.

Yearly Top and Bottom Value

Peloton’s stock is valued at $6.81 at 16:32 EST, way below its 52-week high of $17.83 and way above its 52-week low of $4.28.

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is 46.9% and 55.7%, respectively.

More news about Peloton.

6. Yield10 Bioscience (YTEN) – 9.3%

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the United States and Canada. The company, through its Trait Factory, is involved in developing high value seed traits for the agriculture and food industries. It also has an oilseed development center in Saskatchewan, Canada. Yield10 Bioscience, Inc. has research agreements with Bayer AG to develop traits in soybean; Forage Genetics International, LLC to develop traits in forage sorghum; J. R. Simplot Company to develop novel traits in potato; and GDM Seeds Inc. to evaluate yield traits in soybeans. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was founded in 1992 and is headquartered in Woburn, Massachusetts.

NASDAQ ended the session with Yield10 Bioscience jumping 9.3% to $0.25 on Friday while NASDAQ rose 0.09% to $14,524.07.

Earnings Per Share

As for profitability, Yield10 Bioscience has a trailing twelve months EPS of $-2.7.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -380.77%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 58.2% and 59.2%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Yield10 Bioscience ‘s EBITDA is -1.36.

Sales Growth

Yield10 Bioscience ‘s sales growth for the current quarter is negative 65.5%.

More news about Yield10 Bioscience .

7. AMREP Corporation (AXR) – 8.02%

AMREP Corporation, through its subsidiaries, primarily engages in the real estate business. It operates through two segments, Land Development and Homebuilding. The company sells developed and undeveloped lots to homebuilders, commercial and industrial property developers, and others. As of July 1, 2021, it owned approximately 18,000 acres in Rio Rancho, New Mexico. The company owns tracts of land in Colorado, including 1 property of approximately 160 acres planned for approximately 410 homes. It also owns subsurface oil, gas, and mineral interests covering an area of approximately 55,000 surface acres of land located in Rio Rancho. Additionally, the company focuses on developing single-family detached homes and attached townhomes. AMREP Corporation was incorporated in 1961 and is headquartered in Plymouth Meeting, Pennsylvania.

NYSE ended the session with AMREP Corporation jumping 8.02% to $21.95 on Friday while NYSE jumped 0.24% to $16,755.32.

Earnings Per Share

As for profitability, AMREP Corporation has a trailing twelve months EPS of $3.53.

PE Ratio

AMREP Corporation has a trailing twelve months price to earnings ratio of 6.22. Meaning, the purchaser of the share is investing $6.22 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.47%.

Moving Average

AMREP Corporation’s value is way above its 50-day moving average of $18.38 and way higher than its 200-day moving average of $16.71.

Revenue Growth

Year-on-year quarterly revenue growth declined by 45.2%, now sitting on 40.96M for the twelve trailing months.

More news about AMREP Corporation.

8. Globalstar (GSAT) – 6.02%

Globalstar, Inc. provides mobile satellite services worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational usage, safety, emergency preparedness and response, and other applications. It also provides one-way or two-way communications and data transmissions using mobile devices, including the SPOT family of products, such as SPOT X, SPOT Gen4, and SPOT Trace that transmit messages and the location of the device; commercial Internet of Things transmission products to track cargo containers and rail cars, as well as to monitor utility meters, and oil and gas assets; small satellite transmitter modules, such as the STX-3, ST-150 and ST100, and chips that enable an integrator's products to access company's network; and engineering and other communication services using MSS and terrestrial spectrum licenses, as well as undertakes installation of gateways and antennas. The company distributes its products through retailers, sales force, and e-commerce website. Globalstar, Inc. serves recreation and personal, government, public safety and disaster relief, oil and gas, maritime and fishing, construction, utilities, and transportation, as well as natural resources, mining, and forestry markets. The company was founded in 1993 and is headquartered in Covington, Louisiana.

NYSE ended the session with Globalstar jumping 6.02% to $2.03 on Friday, after two sequential sessions in a row of gains. NYSE jumped 0.24% to $16,755.32, after five successive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Globalstar has a trailing twelve months EPS of $-0.01.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.77%.

Moving Average

Globalstar’s worth is way above its 50-day moving average of $1.39 and way above its 200-day moving average of $1.19.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Globalstar’s stock is considered to be overbought (>=80).

Volatility

Globalstar’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.14%, a positive 1.19%, and a positive 2.69%.

Globalstar’s highest amplitude of average volatility was 2.14% (last week), 2.79% (last month), and 2.69% (last quarter).

Yearly Top and Bottom Value

Globalstar’s stock is valued at $2.03 at 16:32 EST, way above its 52-week high of $1.65.

More news about Globalstar.

9. Grupo Aval Acciones y Valores S.A. ADR (AVAL) – 4.9%

Grupo Aval Acciones y Valores S.A. provides a range of financial services and products to public and private sector customers in Colombia and Central America. It offers traditional deposit services and products, including checking accounts, savings accounts, time deposits, and other deposits. The company also provides commercial loans comprising general purpose loans, working capital loans, leases, loans funded by development banks, corporate credit cards, and overdraft loans; consumer loans, such as payroll loans, personal loans, automobile and other vehicle loans, credit cards, overdrafts, leases, and general purpose loans; and microcredit and mortgage loans. In addition, the company offers pension and severance fund management services; advice related to capital markets, mergers and acquisitions, project finance, and other transactions; mobile and online banking services; and bancassurance, insurance, trust, bonded warehousing and brokerage transactions, real estate escrow services, merchandise and document storage and deposit, customs agency, cargo management, surety bond and merchandise distribution services, and payment and collection services. Further, it is involved in equity investments in various sectors, including infrastructure, energy and gas, agribusiness, and hospitality; and treasury operations. Grupo Aval Acciones y Valores S.A. was incorporated in 1994 and is headquartered in Bogotá, Colombia.

NYSE ended the session with Grupo Aval Acciones y Valores S.A. ADR jumping 4.9% to $2.57 on Friday while NYSE jumped 0.24% to $16,755.32.

Earnings Per Share

As for profitability, Grupo Aval Acciones y Valores S.A. ADR has a trailing twelve months EPS of $0.18.

PE Ratio

Grupo Aval Acciones y Valores S.A. ADR has a trailing twelve months price to earnings ratio of 14.28. Meaning, the purchaser of the share is investing $14.28 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.83%.

Moving Average

Grupo Aval Acciones y Valores S.A. ADR’s value is way above its 50-day moving average of $2.26 and higher than its 200-day moving average of $2.37.

More news about Grupo Aval Acciones y Valores S.A. ADR.

10. Orix Corp (IX) – 4.83%

ORIX Corporation provides diversified financial services in Japan, the United States, Asia, Europe, Australasia, and the Middle East. The company's Corporate Financial Services and Maintenance Leasing segment is involved in the finance and fee; leasing and rental of automobiles, electronic measuring instruments, and ICT-related equipment businesses; and provision of life insurance and environment and energy-related products and services. Its Real Estate segment develops, rents, and manages real estate properties; operates facilities; real estate asset management; manages residential condominiums and office building; and provides construction contracting, real estate brokerage, and real estate investment advisory services, as well as operates hotels and Japanese inns. The company's PE Investment and Concession segment engages in the private equity (PE) investment and concession businesses. Its Environment and Energy segment provides renewable energy; ESCO; retails electric power; sells solar panels and battery electricity storage systems; and recycling and waste management services, as well as generates solar power. The company's Insurance segment sells life insurance products through agents, banks, and other financial institutions, as well as face-to-face and online. Its Banking and Credit segment provides banking and consumer finance services. The company's Aircraft and Ships segment engages in the aircraft leasing and management, and ship-related finance and investment businesses. Its ORIX USA segment offers finance, investment, and asset management services. The company's ORIX Europe segment provides equity and fixed income asset management services. Its Asia and Australia segment offers finance and investment businesses. The company was formerly known as Orient Leasing Co., Ltd. and changed its name to ORIX Corporation in 1989. ORIX Corporation was incorporated in 1950 and is headquartered in Tokyo, Japan.

NYSE ended the session with Orix Corp rising 4.83% to $97.81 on Friday, after two successive sessions in a row of gains. NYSE jumped 0.24% to $16,755.32, after five sequential sessions in a row of losses, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, Orix Corp has a trailing twelve months EPS of $8.32.

PE Ratio

Orix Corp has a trailing twelve months price to earnings ratio of 11.76. Meaning, the purchaser of the share is investing $11.76 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.79%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 3.4%, now sitting on 2.66T for the twelve trailing months.

Volume

Today’s last reported volume for Orix Corp is 8713 which is 42.78% below its average volume of 15229.

Moving Average

Orix Corp’s worth is above its 50-day moving average of $90.72 and above its 200-day moving average of $89.67.

More news about Orix Corp.

Losers Today

1. NASDAQ TEST STOCK (ZVZZT) – -62.85%

NASDAQ ended the session with NASDAQ TEST STOCK falling 62.85% to $11.01 on Friday while NASDAQ rose 0.09% to $14,524.07.

Yearly Top and Bottom Value

NASDAQ TEST STOCK’s stock is valued at $11.01 at 16:32 EST, way below its 52-week high of $25.00 and above its 52-week low of $11.00.

More news about NASDAQ TEST STOCK.

2. VerifyMe (VRMEW) – -39.6%

VerifyMe, Inc., together with its subsidiary, PeriShip Global, LLC, operates as a technology solutions provider that specializes in products to connect brands with consumers and providing brands with end-to-end logistics management for their products. The company operates through two segments, VerifyMe Solutions and PeriShip Global Solutions. The VerifyMe Solutions segment offers technology solutions to connect brands with consumers allowing brand owners to gather business intelligence while engaging directly with their consumers. Its solutions provide brand protection and supply chain functions, such as counterfeit prevention, traceability, consumer engagement solutions, and authentication for labels, packaging, and products, as well as tamper-proof labels. The PeriShip Global Solutions segment offers predictive analytics for optimizing delivery of time and temperature sensitive perishable products. This segment's products include PeriTrack customer dashboard, an integrated web portal tool gives its customers an in-depth look at their shipping activities based on real-time data. It also provides call center, pre-transit, post-delivery, and weather/traffic services. The company has a strategic partnership with INX International Ink Company. The company was formerly known as LaserLock Technologies, Inc. and changed its name to VerifyMe, Inc. in July 2015. VerifyMe, Inc. was incorporated in 1999 and is headquartered in Lake Mary, Florida.

NASDAQ ended the session with VerifyMe sliding 39.6% to $0.03 on Friday, after five consecutive sessions in a row of losses. NASDAQ rose 0.09% to $14,524.07, after five successive sessions in a row of losses, on what was a somewhat up trend exchanging session today.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.16%.

More news about VerifyMe.

3. Xenetic Biosciences (XBIOW) – -34.43%

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and therapeutics. It advances cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. In addition, the company leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. It has collaboration agreements with Takeda Pharmaceutical Co. Ltd., Serum Institute of India Limited, and PJSC Pharmsynthez. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

NASDAQ ended the session with Xenetic Biosciences falling 34.43% to $4.00 on Friday, after five consecutive sessions in a row of losses. NASDAQ rose 0.09% to $14,524.07, after five sequential sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.98%.

More news about Xenetic Biosciences.

4. Catalyst Pharmaceuticals (CPRX) – -13.59%

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

NASDAQ ended the session with Catalyst Pharmaceuticals falling 13.59% to $14.78 on Friday while NASDAQ rose 0.09% to $14,524.07.

Earnings Per Share

As for profitability, Catalyst Pharmaceuticals has a trailing twelve months EPS of $0.55.

PE Ratio

Catalyst Pharmaceuticals has a trailing twelve months price to earnings ratio of 26.88. Meaning, the purchaser of the share is investing $26.88 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.06%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Catalyst Pharmaceuticals’s stock is considered to be overbought (>=80).

Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $14.78 at 16:32 EST, way below its 52-week high of $22.11 and way above its 52-week low of $11.09.

Revenue Growth

Year-on-year quarterly revenue growth grew by 79.4%, now sitting on 348.39M for the twelve trailing months.

More news about Catalyst Pharmaceuticals.

5. WW International (WW) – -11.13%

WW International, Inc. provides weight management products and services worldwide. The company operates in four segments: North America, Continental Europe, United Kingdom, and Other. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program via its Web-based and mobile app products, including personal coaching and digital products; and allows members to inspire and support each other by sharing their experiences with other people on weight management and wellness journeys. In addition, it offers various consumer products, including bars, snacks, cookbooks, kitchen tools, and other products. Further, the company licenses its trademarks and other intellectual property in food, beverages, and other consumer products and services. It offers products through its e-commerce platform, workshops, magazine subscriptions, retail partners, publishing, and third-party advertising in publications; and through Websites and sales from the By Mail product. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1961 and is headquartered in New York, New York.

NASDAQ ended the session with WW International sliding 11.13% to $6.79 on Friday while NASDAQ rose 0.09% to $14,524.07.

Earnings Per Share

As for profitability, WW International has a trailing twelve months EPS of $-0.67.

Sales Growth

WW International ‘s sales growth is negative 7.6% for the ongoing quarter and 1.9% for the next.

Moving Average

WW International ‘s worth is way under its 50-day moving average of $7.64 and way under its 200-day moving average of $8.27.

Yearly Top and Bottom Value

WW International ‘s stock is valued at $6.79 at 16:32 EST, way below its 52-week high of $13.31 and way higher than its 52-week low of $3.46.

Volume

Today’s last reported volume for WW International is 16600100 which is 247.63% above its average volume of 4775220.

More news about WW International .

6. Marathon (MARA) – -10.85%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines digital assets with a focus on the blockchain ecosystem and the generation of digital assets in United States. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Fort Lauderdale, Florida.

NASDAQ ended the session with Marathon sliding 10.85% to $23.42 on Friday while NASDAQ jumped 0.09% to $14,524.07.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-3.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.13%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 671.1%, now sitting on 259.16M for the twelve trailing months.

Moving Average

Marathon’s worth is way above its 50-day moving average of $12.28 and way above its 200-day moving average of $11.38.

Sales Growth

Marathon’s sales growth is 337% for the present quarter and 179.9% for the next.

More news about Marathon.

7. 111 (YI) – -8.74%

111, Inc., through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2019, it operated 12 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Shanghai, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

NASDAQ ended the session with 111 sliding 8.74% to $1.67 on Friday while NASDAQ jumped 0.09% to $14,524.07.

Earnings Per Share

As for profitability, 111 has a trailing twelve months EPS of $-0.46.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -50.6%.

Volume

Today’s last reported volume for 111 is 119693 which is 1.38% above its average volume of 118062.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.5%, now sitting on 14.99B for the twelve trailing months.

Yearly Top and Bottom Value

111’s stock is valued at $1.67 at 16:32 EST, way under its 52-week high of $3.44 and way higher than its 52-week low of $1.19.

Earnings Before Interest, Taxes, Depreciation, and Amortization

111’s EBITDA is -2.27.

More news about 111.

8. Riot Blockchain (RIOT) – -8.58%

Riot Platforms, Inc., together with its subsidiaries, operates as a bitcoin mining company in North America. It operates through Bitcoin Mining, Data Center Hosting, and Engineering segments. The company also provides co-location services for institutional-scale bitcoin mining companies; and critical infrastructure and workforce for institutional-scale miners to deploy and operate their miners. In addition, it engages in the design and manufacturing of power distribution equipment and custom engineered electrical products; electricity distribution product design, manufacture, and installation services primarily focused on large-scale commercial and governmental customers, as well as a range of markets, including data center, power generation, utility, water, industrial, and alternative energy; operation of data centers; and maintenance/management of computing capacity. The company was formerly known as Riot Blockchain, Inc. Riot Platforms, Inc. was incorporated in 1998 and is based in Castle Rock, Colorado.

NASDAQ ended the session with Riot Blockchain falling 8.58% to $14.50 on Friday while NASDAQ jumped 0.09% to $14,524.07.

Earnings Per Share

As for profitability, Riot Blockchain has a trailing twelve months EPS of $-1.8.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.88%.

More news about Riot Blockchain.

9. WISeKey International Holding AG (WKEY) – -7.77%

WISeKey International Holding AG, a cybersecurity company, provides integrated security solutions for the Internet of Things (IoT) and digital identity ecosystems in Switzerland, rest of Europe, North America, the Asia Pacific, and Latin America. The company operates through two segments, IoT and mPKI. It offers microcontrollers and microchips that provides identity to various connected devices; and managed public key infrastructure, which include digital identity, certificate management and signing solutions, and trust services, as well as offers digital certificates, software as a service (SaaS), software license, and post-contract customer support for cybersecurity applications. The company also develops, markets, hosts, and supports a range of solutions that enable secure digital identification of people, content, and objects by generating digital identities through its products and services in cybersecurity services, IoT, digital brand management, and mobile security, which enable clients to monetize their existing user bases, as well as expand its eco-system. In addition, the company operates ISTANA platform that uses cybersecurity SaaS business and semiconductor chips for securing the IoT market, as well as uses artificial intelligence to analyze data; and engages in financing, sales, and distribution activities. WISeKey International Holding AG was founded in 1999 and is headquartered in Zug, Switzerland.

NASDAQ ended the session with WISeKey International Holding AG falling 7.77% to $1.78 on Friday, following the last session’s downward trend. NASDAQ rose 0.09% to $14,524.07, after five successive sessions in a row of losses, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, WISeKey International Holding AG has a trailing twelve months EPS of $16.25.

PE Ratio

WISeKey International Holding AG has a trailing twelve months price to earnings ratio of 0.11. Meaning, the purchaser of the share is investing $0.11 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -30.51%.

Moving Average

WISeKey International Holding AG’s value is above its 50-day moving average of $1.65 and way below its 200-day moving average of $3.59.

Volume

Today’s last reported volume for WISeKey International Holding AG is 59765 which is 9.63% below its average volume of 66136.

Revenue Growth

Year-on-year quarterly revenue growth grew by 39.4%, now sitting on 28.08M for the twelve trailing months.

Yearly Top and Bottom Value

WISeKey International Holding AG’s stock is valued at $1.78 at 16:32 EST, way under its 52-week high of $10.45 and way above its 52-week low of $1.35.

More news about WISeKey International Holding AG.

10. voxeljet AG (VJET) – -6.92%

voxeljet AG provides three-dimensional (3D) printers and on-demand parts services to industrial and commercial customers in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. It operates in two segments, Systems and Services. The Systems segment develops, manufactures, and sells 3D printers. This segment also offers consumables, including particulate materials and proprietary chemical binding agents, maintenance contracts, and spare parts. The Services segment prints on-demand parts for its customers, as well as creates parts, molds, cores, and models using 3D computer-aided design at its service center; and provides casting services. It serves automotive, aerospace, art and architecture, engineering, and consumer product end markets; foundries and suppliers; and universities and research institutes through its direct sales force and a network of sales agents. The company was formerly known as Voxeljet Technology GmbH and changed its name to voxeljet AG in January 2004. voxeljet AG was founded in 1999 and is headquartered in Friedberg, Germany.

NASDAQ ended the session with voxeljet AG falling 6.92% to $1.21 on Friday, after two successive sessions in a row of losses. NASDAQ jumped 0.09% to $14,524.07, after five successive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, voxeljet AG has a trailing twelve months EPS of $-1.14.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -60.46%.

More news about voxeljet AG.

Stay up to date with our winners and losers daily report

Leave a Reply

Your email address will not be published. Required fields are marked *